Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,546.2
30.6 (1.21%)

 

  • STI Straits Times Index
    2,546.2
    30.6 (1.21%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,575.2
    -0.8 (-0.05%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,110.4
    163.8 (0.66%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,377.6
    5.9 (0.17%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,514.8
    -58.8 (-0.26%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,124.5
    49.5 (0.98%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,156.5M
  • Value: 1,018.1M
  • Rise: 214
  • Fall: 102
  • Unch: 492

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.186+0.003
AnAn Intl0.043+0.008
Synagie0.196+0.007
LionGold0.002-
Leader Env0.065+0.009
Medtecs Intl1.030+0.045
CNMC Goldmine0.355+0.045
Anchor Resources0.009+0.002
Genting Sing0.720-0.010
Wilton Resources0.039+0.004

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,253.8 -296.2
HSCEI 9,745.8 -107.4
Jakarta 4,863.1 -41.0
Nikkei 225 22,064.8 -447.3
SSE Comp 2,959.0 -11.7
Shanghai A 3,101.5 -12.2
Shanghai B 211.6 -1.8
KOSPI 2,100.4 -34.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

KITOV PHARMA LTD SPON ADS EACH REP 1 ORD SHS KITOV PHARMA LTD. SPONSORED ADR
Updated on 04 Aug 2020 (End of trading day)
Last (USD): 0.881 Change: +0.056 High: 0.979 Remarks: -
Change (%): +6.82 Low: 0.834
Open 0.834 Yesterday's Close 0.825
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 31,483,210 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.03725 Trailing EPS (USD) e -0.03725 NAV (USD) b 0.0661
PE a - Trailing PE f - Price / NAV b 13.3328
Dividend (USD) d - Cash In Hand (USD) g 0.0278 Issued & Paid-up Shares c 157,553,000
Dividend Yield (%) d - Price / Cash In Hand g 31.701 Treasury Shares h 1
Market Cap (M) 138.851 Enterprise Value (M) 133.117
Piotroski F Score 0 Exchange Code KTOV Par Value ( $ ) n.a.
52 Weeks Volatility (%) 141.80 Free Float (%) 10.1
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 24 Jul 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 15 Apr 2019.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference KITOV PHARMA LTD SPON ADS EACH REP 1 ORD SHS NASDAQ 138.851 - - 13.3328 -
Industry Pharmaceuticals: Major NASDAQ 1,684.287 114.250 1786.655 2.8309 0.008
Local Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 130,400.487 40.078 40.078 1.9712 2.257
Local Peer ROYALTY PHARMA PLC NASDAQ 26,223.912 11.166 11.166 5.0822 -
Local Peer REPLIGEN CORP NASDAQ 8,218.757 383.855 265.644 7.4714 -
Local Peer REATA PHARMACEUTICALS INC NASDAQ 4,997.776 - - 21.8580 -
Local Peer GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 NASDAQ 4,961.846 7.091 6.408 0.8157 -
Local Peer LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS NASDAQ 4,488.204 - - -26.9841 -
Local Peer HUTCHISON CHINA MEDITECH SPON ADS EACH REPR 5 ORD SHS NASDAQ 4,256.344 - - 14.7784 -
Local Peer NEKTAR THERAPEUTICS NASDAQ 3,901.541 - - 3.0095 -
Local Peer ALLAKOS INC NASDAQ 3,885.699 - - 8.1283 -
Local Peer OPKO HEALTH INC NASDAQ 3,590.294 - - - -
Local Peer PRINCIPIA BIOPHARMA INC NASDAQ 2,830.936 - - 8.5411 -
Local Peer TURNING POINT THERAPEUTICS INC NASDAQ 2,407.746 - - 6.3078 -
Other Local Peers KARUNA THERAPEUTICS INC (NASDAQ), APELLIS PHARMACEUTICALS INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), I MAB SPON ADS EACH REP 2.3 ORD SHS (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), CONSTELLATION PHARMACEUTICALS INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), AKCEA THERAPEUTICS INC (NASDAQ), PETIQ INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), ATHENEX INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), GENERATION BIO CO (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), ANNEXON INC (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), TRICIDA INC (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), PROVENTION BIO INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), 89BIO INC (NASDAQ), AC IMMUNE SA (NASDAQ), INOZYME PHARMA INC (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), BIOSPECIFICS TECHNOLOGIES CORP (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), DURECT CORP (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), IMARA INC (NASDAQ), AMAG PHARMACEUTICS INC (NASDAQ), BEYONDSPRING INC (NASDAQ), IMMUNIC INC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), MENLO THERAPEUTICS INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), UROVANT SCIENCES LTD (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), POLYPID LTD (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), LIQUIDIA TECHNOLOGIES INC (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), VERU INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), MUSTANG BIO INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), HARROW HEALTH INC (NASDAQ), GENPREX INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), ESSA PHARMA INC (NASDAQ), XERIS PHARMACEUTICALS INC (NASDAQ), OBSEVA SA (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), GRITSTONE ONCOLOGY INC (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), NOVAN INC (NASDAQ), THE FS ALSEC ALPHASECTOR (NASDAQ), MEDIWOUND LTD (NASDAQ), EVOLUS INC (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), LANTERN PHARMA INC (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), EYENOVIA INC (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), BAUDAX BIO INC (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), AERPIO PHARMACEUTICALS INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), MANNATECH INC (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), MILLENDO THERAPEUTICS INC (NASDAQ), HISTOGEN INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), ENTERA BIO LTD (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), SPRING BANK PHARMACEUTICALS INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), PROPHASE LABS INC (NASDAQ), TELIGENT INC NEW (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ), NOVUS THERAPEUTICS INC (NASDAQ)
Global Peer JOHNSON & JOHNSON NYSE 387,603.760 25.637 25.525 6.1546 2.547
Global Peer PFIZER INC NYSE 213,249.924 13.105 15.049 - 3.789
Global Peer MERCK & CO INC NYSE 206,143.247 20.943 19.672 - 2.784
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 207,603.099 29.455 28.761 3.8580 2.189
Global Peer ABBVIE INC NYSE 166,171.039 21.190 24.013 - 3.907
Global Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NYSE 147,184.203 109.795 96.563 13.6561 2.443
Global Peer ELI LILLY AND COMPANY NYSE 148,109.380 31.935 26.379 36.2087 1.667
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 134,562.174 39.128 141.050 2.6960 2.782
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 117,145.753 20.062 19.496 14.6454 1.759
Global Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 103,456.314 17.459 21.449 - 4.730
Other Global Peers TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), WUXI APPTEC (HKEx), HANSOH PHARMA (HKEx), INNOVENT BIO (HKEx), SINOPHARM (HKEx), CANSINOBIO-B (HKEx), JUNSHI BIO (HKEx), SH PHARMA (HKEx), BAIYUNSHAN PH (HKEx), HENLIUS-B (HKEx), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), CHINAGRANDPHARM (HKEx), CHINARES PHARMA (HKEx), ADC THERAPEUTICS SA (NYSE), CMS (HKEx), AKESO-B (HKEx), HEPALINK (HKEx), HYGEIA HEALTH (HKEx), TRAD CHI MED (HKEx), INNOCARE-B (HKEx), OCUMENSION-B (HKEx), SSY GROUP (HKEx), UNITED LAB (HKEx), ZYMEWORKS INC (NYSE), AMNEAL PHARMACEUTICALS INC (NYSE), CSTONE PHARMA-B (HKEx), CKLIFE SCIENCES (HKEx), TONGRENTANGCM (HKEx), HUA MEDICINE-B (HKEx), Kimia Farma Tbk. (IDX), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), IMMUNOTECH-B (HKEx), IGBB (Bursa), SHINEWAY PHARM (HKEx), TOT BIOPHARM-B (HKEx), FUSEN PHARM (HKEx), AFT PHARMACEUTICALS LTD (ASX), BSTEAD (Bursa), STARPHARMA HOLDINGS LIMITED (ASX), LANNETT CO INC (NYSE), PHARMA (Bursa), PYC THERAPEUTICS LIMITED (ASX), CH BIOTECH SER (HKEx), DAWNRAYS PHARMA (HKEx), ZHONGZHIPHARM (HKEx), IX Biopharma (SGX), Hyphens Pharma (SGX), RECCE PHARMACEUTICALS LTD (ASX), BIOMX INC (NYSE American), Merck Tbk. (IDX), KOTRA (Bursa), NEW RAY MEDIC (HKEx), NOVA (Bursa), Phapros Tbk. (IDX), PALLA PHARMA LTD (ASX), PAK FAH YEOW (HKEx), RACE ONCOLOGY LTD (ASX), CHARMACY PHAR (HKEx), BIOHLDG (Bursa), NC HEALTHCARE (HKEx), IP (SET), ONCOSIL MEDICAL LIMITED (ASX), IMMURON LIMITED (ASX), NEP INTERLONG (HKEx), NOXOPHARM LTD (ASX), TBG DIAGNOSTICS LTD (ASX), AGEX THERAPEUTICS INC (NYSE American), WAI YUEN TONG (HKEx), ANNOVIS BIO INC (NYSE American), SANAI HEALTH GP (HKEx), JCT (SET), PURAPHARM (HKEx), INVION LTD (ASX), EXTRAWELL PHAR (HKEx), MEDLAB CLINICAL LIMITED (ASX), PHARMAXIS (ASX), TIMBER PHARMACEUTICALS INC (NYSE American), SUNZEN (Bursa), ACRUX (ASX), PASHUN INT'L (HKEx), EXOPHARM LTD (ASX), SINOLIFE UTD (HKEx), TALI DIGITAL LIMITED (ASX), CELLMID LIMITED (ASX), SUDA PHARMACEUTICALS LTD (ASX), CRESO PHARMA LTD (ASX), Merck Sharp Dohme Pharma Tbk. (IDX), FIJI KAVA LTD (ASX), Pharmesis Intl (SGX), FARMAFORCE LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.080
+10.02 %
10 Days -+0.084
+10.58 %
20 Days --0.019
-2.08 %
Medium Term Return 3 Months -+0.529
+150.37 %
6 Months -+0.154
+21.22 %
1 Year -+0.151
+20.73 %
Long Term Return 2 Years --1.060
-54.60 %
3 Years --1.039
-54.10 %
Annualised Return Annualised --
-22.86 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.220 - 1.440 Change From 1 Year Low +0.661 % Change From 1 Year Low (%) +300.59
Change From 1 Year High -0.559 % Change From 1 Year High (%) -38.80
2 Years Range 0.220 - 2.920 Change From 2 Years Low +0.661 % Change From 2 Years Low (%) +300.59
Change From 2 Years High -2.039 % Change From 2 Years High (%) -69.82
5 Years Range 0.220 - 6.950 Change From 5 Years Low +0.661 % Change From 5 Years Low (%) +300.59
Change From 5 Years High -6.069 % Change From 5 Years High (%) -87.32
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Kitov Pharma Ltd. is a development stage pharmaceutical company, which engages in drug development. It operates through two segments: Oncology, and Pain & Hypertension. The Oncology segment includes NT219, a therapeutic candidate which is a small molecule that targets two signal transduction pathways which are involved in the development of cancer drug resistance mechanisms, and which is currently in the late pre-clinical stage of development. The Pain & Hypertension segment includes Consensi, a combination drug for the simultaneous treatment of two clinical conditions, pain caused by osteoarthritis and hypertension (high blood pressure), which can be pre-existing or caused by the treatment for osteoarthritis. The company was founded by John Paul Waymack in June 2010 and is headquartered in Tel Aviv, Israel.

Historical Price Data

Date Open High Low Close Volume VWAP
04 Aug 2020 0.834 0.979 0.834 0.881 31,483,210 -
03 Aug 2020 0.820 0.831 0.786 0.825 8,873,820 -
31 Jul 2020 0.790 0.817 0.780 0.803 7,729,695 -
30 Jul 2020 0.800 0.832 0.771 0.780 9,498,275 -
29 Jul 2020 0.762 0.849 0.756 0.801 28,122,380 -
28 Jul 2020 0.761 0.775 0.745 0.768 5,250,261 -
27 Jul 2020 0.800 0.804 0.752 0.761 6,677,617 -
24 Jul 2020 0.764 0.780 0.720 0.750 6,122,458 -
23 Jul 2020 0.791 0.800 0.755 0.770 6,461,869 -
22 Jul 2020 0.829 0.829 0.780 0.797 8,532,178 -
21 Jul 2020 0.753 0.860 0.733 0.814 20,282,280 -
20 Jul 2020 0.767 0.783 0.740 0.763 9,060,467 -
17 Jul 2020 0.770 0.783 0.760 0.769 8,036,872 -
16 Jul 2020 0.786 0.799 0.760 0.793 8,798,514 -
15 Jul 2020 0.730 0.820 0.710 0.795 17,423,220 -
14 Jul 2020 0.740 0.745 0.705 0.725 16,392,240 -
13 Jul 2020 0.800 0.807 0.760 0.769 17,796,670 -
10 Jul 2020 0.832 0.840 0.800 0.821 11,574,400 -
09 Jul 2020 0.899 0.900 0.820 0.852 19,159,700 -
08 Jul 2020 0.922 0.945 0.831 0.900 40,238,970 -
07 Jul 2020 0.790 0.820 0.771 0.786 19,279,800 -
06 Jul 2020 0.868 0.910 0.830 0.860 26,884,890 -
Summary
Current 2 Weeks
(22 Jul 2020 to 04 Aug 2020)
0.829 0.979 0.720 0.881 118,751,763 -
Previous 2 Weeks
(08 Jul 2020 to 21 Jul 2020)
0.922 0.979 0.720 0.814 168,763,333 -
4 Weeks from
(09 Jun 2020 to 07 Jul 2020)
0.508 0.979 0.485 0.786 1,205,266,109 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.